3-hydroxy-3-methyl-pent-4-yn-2-one | 4326-88-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-hydroxy-3-methyl-pent-4-yn-2-one
• 英文别名: 3-Hydroxy-3-methyl-pent-4-in-2-on；3-Methyl-pentin-(1)-ol-(3)-on-(4)；3-hydroxy-3-methylpent-4-yn-2-one
• CAS: 4326-88-9
• 化学式: C₆H₈O₂
• 分子量: 112.128
• InChiKey: VMSNYYMMPHPEMZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  8
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-hydroxy-3-methyl-pent-4-yn-2-one 在 甲酸 作用下， 生成 3-甲基-4-氧代-2-戊烯醛
  参考文献：
  名称：

  Kubota; Takeshima, Journal of the Scientific Research Institute, Tokyo, 1949, vol. 44, p. 186

  摘要：

  DOI：
• 作为产物：
  描述：

  乙炔氢锂 、 alkaline earth salt of/the/ methylsulfuric acid 在 氨 作用下， 生成 3-hydroxy-3-methyl-pent-4-yn-2-one
  参考文献：
  名称：

  HYPNOTICS AND ANTICONVULSANTS. I. TERTIARY ACETYLENIC CARBINOLS

  摘要：

  DOI：

  10.1021/jo01369a014

文献信息

• ALKYNYL ALCOHOLS AS KINASE INHIBITORS
  申请人：Chen Guoqing

  公开号：US20110086834A1

  公开（公告）日：2011-04-14

  Selected compounds are effective for prophylaxis and treatment of inflammation and inflammatory disorders, such as NIK-mediated disorders. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, inflammation and the like.

  所选化合物对于预防和治疗炎症和炎症性疾病（如NIK介导的疾病）有效。本发明涵盖新的化合物、类似物、前药和其药学上可接受的盐、制药组合物和预防和治疗涉及炎症等疾病和其他疾病或病症的方法。
• The Benefit of Houseofficer Education on Proper Medication Dose Calculation and Ordering
  作者：Lewis S. Nelson、Peter E. Gordon、Marc D. Simmons、William L. Goldberg、Mary Ann Howland、Robert S. Hoffman

  DOI：10.1111/j.1553-2712.2000.tb00481.x

  日期：2000.11

  Abstract. Objectives: Drug dosing errors commonly cause morbidity and mortality. This prospective controlled study was performed to determine: 1) residents' understanding of drug dose calculations and ordering; and 2) the short‐term effect of a brief educational intervention on the skills required to properly calculate dosages and order medications. Methods: The study was conducted at an urban public hospital with a four‐year emergency medicine (EM) residency program. The EM residents served as the study group and were unaware of the study design. A written, eight‐question test (T1) with clinical situations and factual questions was administered. Immediately following the test, correct answers were discussed for 30 minutes. Key concepts were emphasized. Six weeks later, a repeat test (T2a) with a similar format was administered to the study group. The same test (T2b) was simultaneously administered to a control group, residents of similar training who did not take T1, in order to determine test equivalency (T1 vs T2). Tests were graded using explicit criteria by a single investigator blinded to the order of administration. Results: Twenty residents completed both tests T1 and T2a. Their mean scores were 48% and 70%, respectively (p < 0.001, paired t‐test). The control group of ten residents had a mean score of 49% (T2b), similar to the study group's scores on T1 (T1 vs T2b, p = 0.40, unpaired t‐test). Conclusion: Emergency medicine residents require specific training in calculating and executing drug ordering. A brief educational intervention significantly improved short‐term performance when retested six weeks later. Long‐term retention is unknown.
• Mikheeva,L.F., Journal of Organic Chemistry USSR (English Translation), 1965, vol. 1, p. 1558 - 1561
  作者：Mikheeva,L.F.

  DOI：——

  日期：——